BioMAP Diversity Early Screening Services

BioMAP Diversity Early Screening Services
Year:
2022

 

The robust BioMAP® phenotypic profiling you trust, in the high quantity screening format you need.

BioMAP Early Screening (ES) services offer an expedited path to physiologically relevant, disease-focused data for large numbers of compounds. Quickly triage, prioritize, and classify your compounds for preclinical success based on translational biomarker activities in human disease models.